ArticleIn silico pharmacology2024

In silico identification and in vitro validation of alpha-hederin as a potent inhibitor of Wnt/β-catenin signaling pathway in breast cancer stem cells.

Tolulope Peter Saliu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.